15 news items
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
presentations from experts and receiving a wide range of important clinical results for the first time. According to analysts
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
presentations from experts and receiving a wide range of important clinical results for the first time. According to analysts
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients
ABBV
11 Jun 24
the BOTOX® Cosmetic grant program in partnership with IFundWomen. The winners were hand-selected by a dedicated panel of experts
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
ABBV
CI
CVS
7 Jun 24
. over the past year, Reuters reports.
This raises concerns among drug pricing experts and analysts about the sustainability
Analyst Scoreboard: 6 Ratings For AbbVie
ABBV
5 Jun 24
Analyst Ratings: A Detailed Breakdown
A clear picture of AbbVie's perception among financial experts is painted with a thorough analysis
ni94mx2 yg67y5o3hq2vghc
ABBV
17 May 24
Ratings: An Elaborate Study
The perception of AbbVie by financial experts is analyzed through recent analyst actions. The following summary
1ycsm5wallh d53wx2ijdtji4rblkf55t0pnzo0gdih3
ABBV
CRBP
CRDL
14 May 24
mfc 7p7ouudxguh4gwkmibtx
ABBV
14 May 24
and oversold.
Next earnings are expected to be released in 72 days.
What The Experts Say On AbbVie
Over the past month
g4h2oinjs4adus115nse4dahajbwrm g50
ABBV
29 Apr 24
An in-depth analysis of recent analyst actions unveils how financial experts perceive AbbVie. The following summary outlines key analysts
omam6b5ur9q4p6mr633skp6zhgorftp 0j0ohg
ABBV
23 Apr 24
.
Next earnings are expected to be released in 3 days.
What Analysts Are Saying About AbbVie
1 market experts have
p1jpyblezlbwzcsyaz
ABBV
15 Apr 24
.
Next earnings report is scheduled for 11 days from now.
What Analysts Are Saying About AbbVie
2 market experts have recently
p9v9dtlqefo2
ABBV
5 Apr 24
In the last month, 2 experts released ratings on this stock with an average target price of $192.5.
An analyst from Barclays
4t2f2sulmax3idw4y v98b19ehm52qtzk3kp8ol8
ABBV
4 Apr 24
for AbbVie
In the last month, 2 experts released ratings on this stock with an average target price of $192.5.
An analyst from
t6igtt1jw5a2pg893skixpav5ipozr
ABBV
25 Mar 24
Moving the Needle on Ethics- its collaboration with medical aesthetics experts from around the globe aiming to elevate discussions
nyx03 qrmpht8c0gc
ABBV
22 Mar 24
: An In-Depth Analysis
A comprehensive examination of how financial experts perceive AbbVie is derived from recent analyst actions. The following
- Prev
- 1
- Next